The upswing for Tetra Bio-Pharma continues as the firm has now confirmed the FDA gave its delta-9-tetrahydrocannabinol drug an orphan designation for treating hepatocellular carcinoma. Shares of a …
More Tetra Bio-Pharma Secures Orphan Drug Designation from FDA Videos